SetPoint Medical Reports Positive Results from its U.S. Pilot Study in Rheumatoid Arthritis
June 17, 2019 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., June 17, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage company developing therapy for chronic autoimmune diseases, today announced positive results from its U.S....
SetPoint Medical to Present Results From The U.S. Pilot Study in Rheumatoid Arthritis Patients at European Congress of Rheumatology (EULAR) 2019
June 03, 2019 13:26 ET
|
SetPoint Medical
VALENCIA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results...
SetPoint Medical to Present at Guggenheim 2019 MedTech Disruptors Summit
May 22, 2019 09:01 ET
|
SetPoint Medical
VALENCIA, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, announced today that Murthy...
SetPoint Medical Reports New Data Demonstrating its Bioelectronic Medicine Effectively Reduces Crohn’s Disease Activity
May 20, 2019 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced new positive...
SetPoint Medical to Present at Bank of America Merrill Lynch Health Care Conference 2019
April 30, 2019 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, announced today that Murthy...
SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for Treatment of Rheumatoid Arthritis (RA)
October 23, 2018 08:01 ET
|
SetPoint Medical
Successful proof-of-concept study demonstrates positive long-term 24-month safety and efficacy data Results to be Presented in Two Poster Presentations Today during the American College of...
SetPoint Medical Completes Enrollment in U.S. Pilot Study Evaluating Bioelectronic Device for Treatment of Rheumatoid Arthritis
October 16, 2018 08:01 ET
|
SetPoint Medical
Proprietary Device Delivers Doses of Electricity to Activate Systemic Anti-inflammatory Response Data Readout Expected in Q1 2019 VALENCIA, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE)...